Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Schwertfeger

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Cardiovascular Pharmacology|September 1, 1995
Dopaminergic and alpha-adrenergic control of neurotransmission in human right atriumL C Rump, G Riera-Knorrenschild, E Schwertfeger, et al.
Kidney International|January 1, 1993
Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slicesL C Rump, E Schwertfeger, M J Schuster, et al.
Clinical Nephrology|November 1, 2007
Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agentS Clorius, K Technau, T Watter, et al.
Kidney International|October 1, 1996
Diagnosis of renovascular disease by intra- and extrarenal Doppler scanningB Krumme, U Blum, E Schwertfeger, et al.
Journal of Hypertension|August 23, 2000
Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipientsL C Rump, V Oberhauser, E Schwertfeger, et al.
Regulatory Peptides|July 16, 2011
PTH-receptors regulate norepinephrine release in human heart and kidneyS A Potthoff, A Janus, H Hoch, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Cardiovascular Pharmacology|September 1, 1995
Dopaminergic and alpha-adrenergic control of neurotransmission in human right atriumL C Rump, G Riera-Knorrenschild, E Schwertfeger, et al.
Kidney International|January 1, 1993
Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slicesL C Rump, E Schwertfeger, M J Schuster, et al.
Clinical Nephrology|November 1, 2007
Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agentS Clorius, K Technau, T Watter, et al.
Kidney International|October 1, 1996
Diagnosis of renovascular disease by intra- and extrarenal Doppler scanningB Krumme, U Blum, E Schwertfeger, et al.
Journal of Hypertension|August 23, 2000
Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipientsL C Rump, V Oberhauser, E Schwertfeger, et al.
Regulatory Peptides|July 16, 2011
PTH-receptors regulate norepinephrine release in human heart and kidneyS A Potthoff, A Janus, H Hoch, et al.
Pageof 2